Bone cancer, Ewing sarcoma, Sarcoma, Soft tissue sarcoma
Results
Phase 2
This trial looked at what the side effects of IMRT are when used to treat bone and soft tissue sarcoma. IMRT is a type of radiotherapy called intensity modulated radiotherapy.
It was open to people who had one of the following:
soft tissue sarcoma of the arm or leg
Ewing’s sarcoma that started in the pelvis or spine
bone sarcoma such as an osteosarcoma or a chondrosarcoma that is high grade in the pelvis and spine
chordoma in the pelvis or spine
Cancer Research UK supported this trial.
The trial was open for people to join between 2016 and 2019. The team published these results in 2024.
Recruitment start: 7 March 2016
Recruitment end: 27 November 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Beatrice Seddon
Cancer Research UK
University College London Cancer Trials Centre (UCL CTC)
The Radiotherapy Trials Quality Assurance (RTTQA) Group
This is Cancer Research UK trial number CRUK/14/015.
Last reviewed: 6 November 2024
CRUK internal database number: 12059
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
